IP Library › Granted Patent US 8,148,379
Granted Patent B2
US 8,148,379 · App. 12/140,927 · Granted Apr 3, 2012

Therapeutic agent for senile dementia

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,148,379
App. No.
12/140,927
Granted
Apr 3, 2012
Kind
B2
Abstract

A therapeutic/preventive agent for cognitive dysfunctions, which comprises as an active ingredient an imide derivative of the following formula [1]: wherein Z is a group of the formula [2]: D is a group of —(CH 2 ) p -A-(CH 2 ) q —; G is ═N—, —CH—, etc.; and Ar is an aromatic heterocyclic group, etc.

Claims (5)

1. A method for treatment of Alzheimer's-type dementia or dementia from Parkinson's disease, which comprises administering an effective amount of an imide compound of the formula [9]:

or an acid addition salt thereof to a mammal in need thereof.

2. The method according to claim 1 , which is for the treatment of Alzheimer's-type dementia.

3. The method according to claim 1 , which is for the treatment of dementia from Parkinson's disease.

4. The method according to claim 2 , which is for the treatment of core symptoms of Alzheimer's-type dementia.

Assignments (2)
CHANGE OF NAME Recorded Nov 21, 2022
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 061972/0730 →
CHANGE OF NAME Recorded Oct 7, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033905/0778 →